Bio Pharma Dive
MARCH 18, 2022
Days after Pfizer asked U.S. regulators to authorize another booster shot for people 65 and older, Moderna has followed with a similar request for all adults, arguing a green light would "provide flexibility" to public health officials and doctors.
Pharma Mirror
MARCH 18, 2022
HONG KONG, Sisram Medical Ltd (the “Company” or “Sisram”, stock code: 1696.HK; together with its subsidiaries referred as the “Group”), a global consumer wellness group, featuring a never-before-seen synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics capital equipment, via injectables therapy, aesthetic dentistry, personal care and more, today announced its audited consolidated annual results for th
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
MARCH 18, 2022
Artificial intelligence advances how scientists explore materials. Researchers from Ames Laboratory and Texas A&M University trained a machine-learning (ML) model to assess the stability of rare-earth compounds. This work was supported by Laboratory Directed Research and Development Program (LDRD) program at Ames Laboratory. The framework they developed builds on current state-of-the-art methods for experimenting with […].
Pharma Times
MARCH 18, 2022
With the significant increase in entries this year, the competition to name the finalists proved incredibly tough. The International Clinical Researcher judging panel, however, have made their decisions and the finalists have now been announced.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
MARCH 18, 2022
The Anaheim Convention Center in California buzzed with an energy that hadn’t been felt since 2019, when the COVID-19 pandemic would soon end in-person events for the foreseeable future. But Natural Products Expo West 2022, a five-day event highlighting the latest natural and organic food and beverage products, saw more than 2,700 exhibitors nearly fill the 480,000 square-foot venue for the first time in over two years. .
Pharma Times
MARCH 18, 2022
The hybrid of Delta and Omicron, known as ‘Deltacron’, has been identified in France, Denmark and the Netherlands
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
MARCH 18, 2022
Tokyo, Japan – Researchers from Tokyo Metropolitan University have developed a new quasi-solid-state cathode for solid-state lithium metal batteries, with significantly reduced interfacial resistance between the cathode and a solid electrolyte. By adding an ionic liquid, their modified cathode could maintain excellent contact with the electrolyte. Their prototype battery also showed good retention of capacity. […].
Drug Channels
MARCH 18, 2022
Today’s guest post comes from Ashwin Mundra, Chief Revenue Officer at Kalderos. As Ashwin explains, manufacturers face a gap between visible, non-compliant drug discounts and the actual level of non-compliant discounts. He describe Kalderos’ technology-enabled, machine learning-based methods for identifying drug discount non-compliance. To learn more, register to receive a copy of Kalderos’ annual report, available April 13, 2022: Conquering the “Great Unknown”: Connecting the data gaps that kee
Scienmag
MARCH 18, 2022
Minamata, a British film released in 2021, is based on the true story of an American photographer documenting how the citizens of Minamata, Japan, became ill due to the industrial discharge dumped into the river by a Japanese corporation. The Minamata disease, mentioned in the movie, is a neuromuscular disorder resulting from mercury poisoning. To […].
Pharma Times
MARCH 18, 2022
Approval is significant as waning restrictions present significant threats to many immunocompromised people across the UK
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
MARCH 18, 2022
An investigation into how human nerve cells differ from animal cells has provided researchers from The University of Texas at Dallas’ Center for Advanced Pain Studies (CAPS) with important clues in the pursuit of more effective treatments for chronic pain. Credit: University of Texas at Dallas An investigation into how human nerve cells differ from animal cells […].
Clairnes
MARCH 18, 2022
The post The right way to use social media for clinical trial recruitment appeared first on Clinical Trial Recruitment & Management Services.
Scienmag
MARCH 18, 2022
UNLV researchers have discovered a new form of ice, redefining the properties of water at high pressures. Credit: Chris Higgins UNLV researchers have discovered a new form of ice, redefining the properties of water at high pressures. Solid water, or ice, is like many other materials in that it can form different solid materials based […].
pharmaphorum
MARCH 18, 2022
AstraZeneca (AZ), GlaxoSmithKline (GSK), Sanofi, Allergan and Britannia Pharma have been reprimanded for running advertisements that breached the Association of British Pharmaceutical Industry (APBI) code of practice. Complaints upheld by the Prescription Medicines Code of Practice Authority (PMCPA) include two against AZ and Allergan – now part of AbbVie – related to promotion of medicines on social media sites, including LinkedIn.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
MARCH 18, 2022
In the very beginning of the COVID-19 outbreak (February, 2020), a proteomics expert, Dr. Jun Qin (State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics) and a clinical doctor, Dr. Zhongde Zhang (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine), who worked in […].
pharmaphorum
MARCH 18, 2022
Merck & Co’s Keytruda is poised to move even earlier in the treatment of patients with non-small cell lung cancer (NSCLC) after showing efficacy when used to prevent the cancer returning after surgery to remove it in a phase 3 trial. The results of the KEYNOTE-091 trial showed that Keytruda (pembrolizumab) reduced death or disease recurrence by 24% compared to placebo when used as adjuvant therapy after surgery in an all-comer NSCLC population regardless of PD-L1 expression.
Scienmag
MARCH 18, 2022
Polarization, the direction in which light vibrates, provides a lot of information about the objects with which it interacts, from aerosols in the atmosphere to the magnetic field of stars. However, because this quality of light is invisible to human eyes, researchers and engineers have relied on specialized, expensive, and bulky cameras to capture it. […].
The Pharma Data
MARCH 18, 2022
Sanofi will give its shareholders the opportunity to be part of EUROAPI’s new chapter of growth through an additional extraordinary dividend in kind EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions The French State, through the fund French Tech Souveraineté, intends to acquire 12% of EUROAPI’s capital for up to €150 million from Sanofi to become a long-term reference shareholder of EUROAPI As planned, Sanofi will continue to hold circa 30% of EUROAPI, p
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MARCH 18, 2022
Huntington’s disease1 is caused by a mutation in the Huntingtin gene, a protein necessary for the proper functioning of several brain cells. Mutated, it is no longer able to perform properly: it can even become toxic for the neurons, triggering a defence mechanism in the brain. In turn, the astrocytes, the neurons’ support cells, change […].
The Pharma Data
MARCH 18, 2022
Columbia Engineering researchers report that they have developed a “cloaking” system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer cells in mice. By manipulating the microbes’ DNA, they programmed gene circuits that control the bacteria surface, building a molecular “cloak” that encapsulates the bacteria. “What’s really exciting about this work is that we are able to d
Scienmag
MARCH 18, 2022
BOSTON — Once considered to be inert, white adipose tissue is now recognized to be dynamic and to play an interactive role in a wide array of biological and metabolic processes. Diet and energy expenditure can cause dramatic changes to the physiology, behavior and cellular make-up of white adipose tissue, and these changes, in turn, are […].
Drug Patent Watch
MARCH 18, 2022
Annual Drug Patent Expirations for DEFINITY Definity is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. There are five patents…. The post New patent for Lantheus Medcl drug DEFINITY appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MARCH 18, 2022
Overview Credit: COPYRIGHT (C) TOYOHASHI UNIVERSITY OF TECHNOLOGY. ALL RIGHTS RESERVED. Overview Researchers including Associate Professor Hiroto Sekiguchi in the Department of Electrical and Electronic Information Engineering at Toyohashi University of Technology, Associate Professor Noriaki Ohkawa in the Comprehensive Research Facilities for Advanced Medical Science at Dokkyo Medical University, and Assistant Professor Izumi Fukunaga in […].
Drug Patent Watch
MARCH 18, 2022
Annual Drug Patent Expirations for DEFINITY+RT Definity Rt is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. There are five…. The post New patent for Lantheus Medcl drug DEFINITY RT appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
MARCH 18, 2022
Arup K. SenGupta’s wide-ranging contributions to water science and technology and expanding access to safe drinking water will be recognized next week at the Spring 2022 meeting of the American Chemical Society (ACS) through a three-day symposium on “Ion Exchange, Sustainable Separations, & Humanitarian Engineering.” Credit: Lehigh University Arup K.
Drug Patent Watch
MARCH 18, 2022
Annual Drug Patent Expirations for OXLUMO Oxlumo is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are eleven patents protecting this drug. This drug…. The post New patent for Alnylam Pharms drug OXLUMO appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MARCH 18, 2022
Engineers at the University of Cincinnati have developed a promising electrochemical system to convert emissions from chemical and power plants into useful products while addressing climate change. Credit: Jingjie Wu/UC Engineers at the University of Cincinnati have developed a promising electrochemical system to convert emissions from chemical and power plants into useful products while addressing […].
Drug Patent Watch
MARCH 18, 2022
Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs. This is one of the longest exclusivity terms provided by…. The post Pharmaceutical companies with the most ‘New Chemical Entity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
MARCH 18, 2022
Laboratory studies of lung tissue usually require the removal of large amounts of human or animal tissue. Now scientists from the University of Freiburg’s Faculty of Medicine have succeeded in collaboration with American researchers in generating tiny quantities of lung tissue, so-called organoids, from just a few body cells in the lab. The tissue forms […].
The Pharma Data
MARCH 18, 2022
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab 1. In RELATIVITY-047, Opdualag more than doubled median progression-free survival compared to nivolumab monotherapy, an established standard of care 1,2. Relatlimab is the third immune checkpoint inhibitor from Bristol Myers Squibb, adding to the Company’s growing and differentiated oncology portfolio.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
148 
Let's personalize your content